High Purity 99.0%Min.Enfuvirtide Acetate Raw Peptide Powder CAS No.: 159519-65-0 GLP-1 Research Chemical
Appearance White powder
Purity (HPLC) ≥95.0%
Simple impurity≤1.0%
Acetate content 5.0%~12.0%
Moisture content≤10.0%
Peptide content ≥ 80.0%
Packaging and Shipping:
Low temperature, vacuum packaging, accurate to milligrams upon request.
Product Description:
Enfuvirtide acetate was approved by the US FDA in 2003, and it is used in combination with other anti-HIV drugs in the treatment of HIV infection. Enfuvirtide is a new type of antiretroviral drug, and it has been the pioneer of anti-AIDS treatment drugs in the past seven years. Enfuvirtide mimics the HR2 domain and is a 36 amino acid polypeptide derived from HIV-1 gp41 protein. It is a selective and effective inhibitor of HIV-1 fusion and infection. It can bind to the HR1 trimer helix and prevent HR1- Formation of HR2 six-helix bundles, thus preventing fusion of viral particles with host cells.
Storage method: Freeze-dry at -20°C and store in the dark
Remarks: For research only, not for human use
HOT SELLING
Semaglutide CAS 910463-68-2
Tirzepatide CAS 2023788-19-2
Retatrutide CAS 2381089-83-2
Liaglutide CAS 204656-20-2
Octreotide CAS79517-01-4
Dulaglutide CAS 923950-08-7
LixisenatideAcetate CAS 320367-13-3
Teduglutide CAS 197922-42-2
Albiglutide CAS 782500-75-8
Degarelix CAS 214766-78-6
Cilengitide CAS 188968-51-6
Mifamurtide CAS 83461-56-7
Somatostatin CAS 51110-01-1
Exenatide Acetate CAS 141732-76-5
Pramlintide CAS 151126-32-8
Eptifibatide CAS 188627-80-7
Bivalirudin CAS 128270-60-0
Semax CAS 80714-61-0
China
